application of physiologically-based pharmacokinetics (pbpk) to personalized dosing
Published 3 years ago • 1K plays • Length 1:05:52Download video MP4
Download video MP3
Similar videos
-
57:41
application of pbpk modeling & simulation to support dose selection in special populations
-
40:57
precision dosing using pbpk modeling
-
59:17
applications of pbpk modelling for regulatory submissions: case studies
-
39:27
the physiological basis of comparative pharmacokinetics
-
58:30
predicting drug exposure during pregnancy using pbpk models
-
1:04:00
survival of the fittest: evolving pharmacokinetic modeling with pirana
-
47:14
pml school: minimal physiologically-based pharmacokinetic model for monoclonal antibodies (mabs)
-
55:39
a best practice framework for applying pbpk modeling to pediatric drug development
-
22:23
application of pbpk modelling to drug development decisions | joga gobburu, phd, mba
-
38:36
getting at the haart of precision dosing: using pbpk models to optimize dosing of an antiviral
-
59:23
first-in-human (fih) faster: the power of physiologically based pharmacokinetic (pbpk) modeling
-
19:56
pbpk to guide study design and product development for generic dermatological products
-
15:43
module 7 – case study 5: application of pbpk models in eliglustat clinical development
-
36:24
physiologically-based pharmacokinetics modeling: an approach for designing better clinical trials
-
50:40
application of pbpk modeling in predicting p-glycoprotein-mediated drug-drug interactions
-
1:52
pbpk modeling supports approval of breakthrough cancer drug
-
59:17
strategic application of pbpk models for predicting ddis & the effects of smoking & organ impairment
-
21:52
fda’s perspective on physiologically based pharmacokinetic analyses for biopharmaceutic applications
-
50:49
pbpk modeling and simulation for regulatory decision making: impact on us prescribing information
-
1:02:16
leveraging dermal pbpk modeling and simulation approaches